Isofol Medical AB (SE0009581051) — research page
SE · se-cm-kg/XSTO/SE0009581051 · as of 2026-11-06
Identity and listing
The issuer is Isofol Medical AB, listed on Nasdaq Stockholm under the ticker SE0009581051, with ISIN SE0009581051 and LEI 549300MCXYAHG7VBHX75. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Isofol Medical AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0009581051 | source · 2026-11-06 |
| ISIN | SE0009581051 | source · 2026-11-06 |
| LEI | 549300MCXYAHG7VBHX75 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 24 filings in the twelve months to 2026-11-06, across 22 filing days. The median gap between filing days is 13 days. The latest filing is dated 2026-10-28 and is of type Other information disclosed according to the rules of the Exchange, 9 days before the record date. The exchange median for filings is 30.0, for cadence 9.5 days, and for latency 7.0 days, across 398 issuers on Nasdaq Stockholm. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 24 | 13 | 9 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Isofol appoints nomination committee ahead of the 2027 Annual General Meeting |
| 2026-10-13 | Investor News | Investor News | Isofol invites to an Investor & Scientific Update in Stockholm and Gothenburg on November 12 and 13, respectively |
| 2026-09-22 | Investor News | Investor News | Isofol to present at upcoming investor meetings |
| 2026-08-25 | Half Year financial report | Half Year financial report | Isofol Medical AB (publ) publishes interim report, January - June 2026 |
| 2026-08-24 | Investor News | Investor News | Isofol expands the number of study sites to accelerate patient recruitment in cancer study |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.
Orderability
The outcome cannot be determined, because the chapter's orderability section carries no client categories. Rule version acm-68000/se/mifid-ii-product-governance/r1 applies, with the chapter as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
Two research houses are named on the issuer's investor-relations page: Redeye and ABG Sundal Collier.
| research house | analyst | source · read date |
|---|---|---|
| Redeye | Kevin Sule | issuer page · 2026-11-12 |
| ABG Sundal Collier | Georg Tigalonov-Bjerke | issuer page · 2026-11-12 |
Open research
The record holds one openly published research note, by ABG Sundal Collier, dated 2026-01-01.
| date | publisher | note | kind |
|---|---|---|---|
| 2026-01-01 | ABG Sundal Collier | Isofol Medical | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed, and no issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0009581051 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://isofolmedical.com/investors/analysts/ (coverage)
- 10.7
- https://isofolmedical.com/wp-content/uploads/2026/01/2026-01-ABG-Isofol-equity-research-.pdf (open research)
- 10.8
- https://mcp.se-cm-kg.ai/record/XSTO/SE0009581051 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0009581051"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:302c37904397fa24.